TECHNOLOGY FACTS

MRI-guided Radiation Therapy Systems Market is Driven by the Increasing Adoption of Radiotherapy in Cancer Treatment

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR. This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.

To garner Additional Information on the Competitive Dynamics, Get the Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=2572

The study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree. In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.

The study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019. Opportunities abound for of MRI-guided radiation therapy system developers,, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT (Linear accelerators integrated with magnetic resonance radiotherapy).

Customize the Report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=2572

The study also finds that radiotherapy centers are adopting technologically-advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective. Market players are focusing on building a successful consortium with the help of physicians, clinicians, as well as Original Equipment Manufacturers (OEMs), to tap opportunities in the radiation therapy centers.

The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America. In 2017, the per capita health expenditure was over US$10,000 in the U.S., recording an increase of nearly 4% over 2016, according to studies. In addition, an alarming rise in the prevalence of cancer in the U.S. will reflect in a significant demand for MRI-guided radiation therapy systems in North America.

According to the study, North America accounted for 45% sales of MRI-guided radiation therapy systems in 2018. Healthcare organizations in the region are investing heavily in tech-driven radiation treatments for cancer. While demand remains robust in developed markets, developing economies are also emerging as attractive markets for MRI-guided radiation therapy systems. Increasing government investments in healthcare infrastructure in the region, are expected to create new opportunities for the players in the MRI-guided radiation therapy systems market.

Read Report Summary: https://www.factmr.com/report/2572/mri-guided-radiation-therapy-system-market

About Us

We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.

Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.

Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.

Contact Us

Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593

Oncology Small Molecule Drugs Market – Investing in Early Cancer Diagnosis and Therapeutics to Drive the Market

Global sales of oncology small molecule drugs were valued at ~US$ 63 Bn in 2018, in line with the widespread prevalence of cancer and subsequent need for oral, easily absorbable, and effective medicines. North America, spearheaded by the U.S., is anticipated to remain the leading as well as high growth market for oncology small molecule drugs during the foreseeable period. With high treatment seeking rate and favorable reimbursement scenarios for cancer treatment, the US is estimated to witness revenues worth ~US$ 30 Bn in 2019.

Read Report Summary: https://www.factmr.com/report/3747/oncology-small-molecule-drugs-market

According to the Fact.MR study, the oncology small molecule drugs market will continue to remain consolidated with top five players, including Novartis Ag, Astrazeneca, Genentech, Pfizer, and Abbvie, accounting for ~47% market value share. These players are emphasizing strong regional presence, robust R&D, new launches, and diverse offerings to stay ahead of the competition in oncology small molecule drugs market, which compels companies to enter strategic collaborations with recognized biopharma companies. For instance, recently in June 2019, Pfizer announced the decision to buy the oncology specialist Array BioPharma, marking an important acquisition beefing up the former’s oncology offerings with two marketed drugs – BRAF inhibitor Braftovi, and MEK inhibitor Mektovi. These two drugs have been approved as a part of the combination treatment for melanoma, and have delivered proven positive results in case of colon cancer.

Mid-level players, such as Roche, Bayer, Genzyme Corporation (Sanofi), and Eli Lilly and Company, are focusing on penetration into developing economies, looking at their market attractiveness. Development of novel treatment options to appeal a wider patient pool will be a priority strategy adopted by prominent players in this category. The market entrants, on the other hand, are likely to remain focused on expansion of the manufacturing capacities to better their foothold in local and regional markets. Amid the growing competition in the oncology small molecule drugs market, partakers are vying to squeeze profit margins by developing low-cost variants, with an objective to firm up in developing regions.

Get Sample PDF File: https://www.factmr.com/connectus/sample?flag=S&rep_id=3747

High prevalence of cancer, coupled with the notable preference for more effective drugs that can easily enter and get absorbed in the cells is primarily boosting sales of oncology small molecule drugs. Increasing awareness about the availability of novel and easily absorbable drugs for cancer treatment is providing an impetus to oncology small molecule drugs sales.

Modulating the immune system via a small-molecule approach offers several unique benefits that are complementary to, and potentially synergistic with, biologic modalities. An increasing number of biopharma companies are thus utilizing ‘selective targeting small molecules’ that accurately exploit the vulnerabilities in cancer cells. Such a pragmatic approach towards cancer is likely to create a plethora of opportunities in terms of new product developments in the oncology small molecule drugs market. While small molecules account for ~70% of the newly developed molecular entities (NME), as approved by the FDA in 2018, it is highly likely that industry giants will refocus their oncology drug development strategies around the use of these small molecules. Subsequent approvals of oncology small molecule drugs are also creating a steady stream of opportunities in the market. For instance, Pfizer’s Daurismo (glasdegib) received an approval for the treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients.

Growing traction for targeted therapy as a vital type of cancer treatment continues to expand the bandwidth of opportunities for the manufacturers of oncology small molecule drugs. Development, quicker regulatory approval, and subsequent adoption of small molecule drugs to block the process that aids cancer cells multiply and spread, continue to uplift the oncology small molecule drugs market. Furthermore, growing FDA approvals of oncology small molecule drugs, such as larotrectinib (Vitrakvi) as a type of targeted therapy that aims a specific genetic change known as NTRK fusion, continue to add gains into the market.

Inquire for a Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=3747

Auto Infotainment Market – Rising Demand for Customization of Car Systems to Boost the Market

Continuous innovations driven by electronics are being observed in the automotive industry. High tech electronics offer passengers as well as drivers with various systems within the vehicle, for instance, in-car navigation system. In addition, all information and entertainment can be delivered through wireless technology making it convenient for the vehicle occupant. Today’s consumer is more focused on auto infotainment technology incorporated in a car’s dashboard rather than the components present under its hood. Credited to super semiconductor growth, microelectronics has enhanced auto infotainment systems, by improving their functionality and output.

Read Report Summary: https://www.factmr.com/report/584/auto-infotainment-market

Auto infotainment is the ongoing megatrend that is gaining traction in modern vehicles that is fuelling the ubiquity of microelectronics. Consumers are more eager to get connected and access their content at any point in time and at any place on their devices with convenience. Connected car is highly safe, energy efficient and comfortable that provides information on weather, traffic and road accidents.

According to Fact.MR analysis, demand for auto infotainment is expected to increase at a value CAGR of 6.4% during the period of forecast, 2017-2026. By end of the assessment period, sale of around 259,380 thousand auto infotainment units is expected. With integration of multimedia and smartphones in infotainment systems, multiple features have become possible, for instance, tracking systems, telematics and navigation that are revolutionizing the auto infotainment market.

Increasing consumer focus on entertained driving and high demand for car customization supported with high per capita income is expected to fuel the demand for auto infotainment systems. Key players involved in the global auto infotainment market include Continental AG, HARMAN International, DENSO CORPORATION, Delphi Automotive LLP, FUJITSU TEN LIMITED and Garmin Ltd.

Get Sample PDF File: https://www.factmr.com/connectus/sample?flag=S&rep_id=584

Automotive Grade Linux (AGL) is accelerating auto infotainment applications, directing car makers towards connected cars. AGL collaborative project is connecting technology companies, suppliers and car makers to speed up the adoption and development of completely open software pile for connected cars. Car makers, for instance Toyota, are promoting activities associated with automotive grade Linux with a view to promote developments in auto infotainment systems. Automotive Grade Linux is planning to enhance entire software stack in the vehicle, which includes head up display, ADAS (Advanced Driver Assistance Systems), telematics instrument cluster as well as autonomous driving. This is expected to have a positive impact on automotive infotainment market.

Carmakers have gone over the edge with respect to automation in automotive infotainment. Recent innovations and developments include voice control for infotainment systems that car makers are offering. They are turning to Google (Android Auto), Amazon and Apple (CarPlay) to provide seamless solutions. For example, Toyota has incorporated Amazon’s Alexa – a cloud based voice control model – in few of its new models. With Alexa passengers or drivers can control the movement of the car as well as infotainment systems, including selecting songs, playing movies, changing destinations, as well as control smart home devices from far afield. Such innovations are supporting the adoption of auto infotainment systems, making consumers to integrate them to their vehicles.

Automotive industry across the globe has taken a new turn towards introducing new developments in vehicles. Automotive sector in Asia Pacific excluding Japan region has remained strong with growing sales of passenger cars across emerging economies. Owing to high population preferring cars in countries such as China and India, it has become necessary for manufacturers to enhance their production capacities. Moreover, with ongoing innovations in cars, especially in infotainment, people are more inclined towards adopting advanced and latest systems for their vehicles. This has contributed to the sale of auto infotainment systems in APEJ, thus fuelling growth of the global market.

Inquire for a Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=584

Autologous Fat Grafting Market to be The New Horizon of Aesthetic Medicine

Demand for autologous fat grafting procedures accounted for the revenues worth US$ 317 Mn, in 2018. Continued preference for the use of non-invasive aesthetic techniques in skin rejuvenation is primarily favoring the growth of autologous fat grafting market.

Read Report Summary: https://www.factmr.com/report/2701/autologous-fat-grafting-market

The four leading companies that account for the consolidation of the competition landscape of autologous fat grafting market, continue to represent a whopping 80% share in the revenues. Allergan, MicroAire, Alma Lasers, and Human Med are expected to primarily maintain their strategic focus on partnerships and acquisitions with smaller yet active players. The latter are typically specialized in the development of meniscus repair systems for treating meniscal scars. With this, leading companies operating in autologous fat grafting industry, are eyeing feasibility of entry in the meniscal scars treatment landscape. Increasing strategic tie-ups among manufacturers of systems & accessories, and recognized research institutions, aim to ensure sufficient device supply and superior post-sales service.

Manufacturers in the autologous fat grafting market are also investing efforts in introducing innovative products, to enhance their market shares. For instance, in 2019, Alma Lasers (Sisram Medical) announced the availability of BeautiFill as the novel laser-based technique for fat harvesting, while leveraging autologous fat to restore the volume to body or face. As cellular therapies are increasingly being perceived as mainstream therapeutic option, there has been a surge in demand for adipose derived stem cells (ADSC), which is potentially applicable in tissue engineering and regeneration. Additionally, a growing focus of leading players on introducing advanced systems & accessories is likely to extend applicability of their offerings, leveraging untapped opportunities in the autologous fat grafting market.

Autologous fat grafting continues to garner traction as a viable replacement for invasive cosmetic surgery methods, as the consumer demand for younger, fuller skin – with minimal skin invasion – remains high. Additionally, advantages of fat grafting procedures, including rapid recovery with lesser allergic risks and reduced downtime, are spurring the demand at a global level. Growing adoption of autologous fat transfer for soft tissue augmentation has paralleled the rising traction for liposuction body contouring, while creating a readily available, low-cost product for lipo-grafting, the application of lipo-aspirated material.

Get Sample PDF File: https://www.factmr.com/connectus/sample?flag=S&rep_id=2701

Pre-pectoral breast reconstruction is re-emerging as a promising alternative to sub-muscular implants, as they assure lower risk of further complexities, such as muscular impairment, pain, and animation deformity. Although research on the feasibility of use of autologous fat grafting techniques in pre-pectoral breast reconstruction is still in its infancy, the possible aesthetic excellency and superior functional outcome remain lucrative for the market growth in future.

In addition to their aesthetic capabilities, the autologous fat grafting procedure has been recently representing an interesting outlook owing to its regenerative properties. A number of plastic surgeons are thus currently looking forward to leverage the high concentration of mesenchymal stem cells (MSCs) within fat tissues, for assessing their role in the process of regeneration.

Autologous fat grafting technique continues to witness frequent technical modifications. The adoption of autologous fat grafting as a technique to augment and regenerate deficient, irradiated, and aged subcutaneous soft tissue and skin, with minimal complication rate and donor-site morbidity, has grown spectacularly over the recent past. An approach garnering research interests for its potential role in enhancing volumetric retention of fat grafts, involves insertion of autologous platelet-rich fibrin (PRF) into graft tissues. A relevant study indicates PRF as a concentrate that may enhance the outcome of fat grafting for plastic surgery procedures. This newer biomaterial with several potential advantages, such as simpler preparation with no external additive, is likely to trigger new product developments in the autologous fat grafting market.

Inquire for a Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=2701

Seed Drill Machines Market to Reach a Value of Nearly US$ 620 Mn by the End of 2026

Global demand for seed drill machines is projected to grow at a moderate rate during the assessment period 2017-2026. The growth is likely to mimic broader developments in the global farm machinery market. The industry has been impacted by poor crop prices, and although there has been slight recovery, the projections are not overly encouraging.

Read Report Summary: https://www.factmr.com/report/523/seed-drill-machines-market

In addition to demand in developed markets, the adoption of seed drill machines in developing regions is growing on account of a slew of factors. A significant percentage of population is migrating to non-farming jobs, which has posed challenges in terms of availability of labor. Further, growing awareness on the benefits of using seed drill for sowing seeds vis-à-vis manual sowing is also leading to increased adoption.

Although demand for seed drill machines has remained steady over the years, broader challenges in the agriculture sector have led to a slowdown in sales. Seed drill machines have long replacement cycles, and the advances in drill machines haven’t been so revolutionary so as to induce an upgrade. It is on the back of a hangover of the slowdown in broader agriculture sector that the demand for seed drill machines is likely to grow at a moderate pace.

The concept of leasing seed drillers is gaining ground among farm owners, with new rental businesses springing up to cater to the growing demand. Leasing is likely to gain further momentum in the near future, owing to the waning perception towards equipment ownership. The emphasis on lowering operational costs is also likely to provide an impetus to used seed drillers.

Get Sample PDF File: https://www.factmr.com/connectus/sample?flag=S&rep_id=523

Demand for seed drill machines continues to grow at a brisk pace in Asia Pacific excluding Japan (APEJ). The demand is especially higher in China and India, as a significant percentage of the population is engaged agriculture as a means of livelihood. The agriculture sector in both China and India is witnessing a transformation, as farm owners have to adapt to the changes in the workforce availability. According to estimates, over 10 million farm workers have shifted to non-agriculture based jobs in India over a decade. The limitation in terms of lack of labor is influencing farm owners to invest in farm machinery and equipment. The scenario is not starkly different in China, where a steady adoption of seed drill machines has been witnessed in the last decade or so.

In many countries of Asia Pacific, mechanization was limited to the use of tractors and harvesters. The use of machines for sowing remained an afterthought for many years, however, investment has witnessed a steady increase in the recent past. Although the adoption rate is impressive, there is lot of scope for further penetration of seed drill machines.

Sensing the unique opportunities in agrarian societies such as China and India, manufacturers are focusing on raising awareness on the benefits of seed drill machines. The high input and low output challenge associated with manual sowing can be countered with the use of seed drill machines, and manufacturers are positioning their products on these lines. The rising seed and fertilizer costs are putting pressures on farm owners to increase productivity, and seed drill machines have emerged as a prudent option.

Inquire for a Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=523

Overall, the outlook on the global seed drill machines market remains positive, however, it is highly likely that growth will be sluggish over the forecast period.

Gonorrhea Therapeutics Market will Influenced by Increased Attention on New Developments in Novel Therapeutic Compounds

According to our study, the gonorrhea therapeutics market will remain a fairly fragmented landscape, with a large number of contenders collectively holding relatively greater shares than the frontrunners and competitors in the market. With ~40% market shares, the contenders are competing with product innovations in active therapy areas, targeted drug delivery, and capacity expansion to meet growing demand for therapeutics abreast escalating prevalence of gonorrhea. Frontrunners in the gonorrhea therapeutics market are focusing more on diagnostic tests and services, and R&D dedicated to biosimilars and generics.

Read Report Summary: https://www.factmr.com/report/3761/gonorrhea-therapeutics-market

The stakeholders in the gonorrhea therapeutics market are more focused on strengthening their distribution in untapped markets, even as entering into strategic partnerships with local distributors to enhance their supplier force and propel sales. Growing prevalence of antibiotic-resistant gonorrhea has meant that the need for new drugs is evident, as a significant chunk of the global demographic falls prey to the Neisseria gonorrhea bacteria annually. Although progress in gonorrhea vaccines has slugged in the past, recent advances allude an uptick, with conserved vaccine antigens that stimulate bactericidal antibodies being recognized.

New drug developments and laser-sharp focus on quick approvals will remain key winning imperatives for stakeholders in the gonorrhea therapeutics market, in turn complementing their brand repositioning strategies. Prospects for the gonorrhea therapeutics market seem bullish, with key players increasingly vying for geographical presence, new drug launches, and stable supply chain logistics.

Increasing prevalence of gonorrhea, coupled with the rising public awareness about STDs (Sexually-Transmitted Diseases), and advances in relevant diagnostic methods, are the key growth determinants of the gonorrhea therapeutics market. Rising incidence of gonorrhea has led to the advent of new diagnostic tests, such as nucleic acid amplification tests (NAATs), which enable early screening to keep the infection from spreading to the upper genital tract.

Get Sample PDF File: https://www.factmr.com/connectus/sample?flag=S&rep_id=3761

Preference for NAATs over traditional cultures has grown significantly in recent years owing to their improved sensitivity and selectivity for Neisseria gonorrhoeae at rectal and oropharyngeal sites in men. Such increased availability and adoption of testing modalities is driving the demand for gonorrhea therapeutics. Low cost of gonorrhea therapeutics continues to favor its market prospects, while stakeholders eye to capitalize on the pricing value of widely used STD drugs, such as Ceftriaxone.

Antimicrobial resistance (AMR) has become a rapidly growing global public health threat. With AMR making more than 375 million annual new cases of sexually-transmitted infections (STIs) that are stringent to treat, there has emerged a dire need to tackle this upcoming health crisis. The bacteria that causes gonorrhea is particularly prone to drug resistance, and is classed as ‘high priority’ for renewed antibiotic R&D by leading health organizations.

Turning into a global public health concern, in line with the high unmet need for gonorrhea treatment, growing prevalence of this infection has propelled organizations to collaborate and develop a novel treatment in this light. For instance, Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) had collaborated to co-develop a new drug zoliflodacin, specifically to treat drug-resistant gonorrhea, while hoping to provide a solution. Zoliflodacin is a new and first-in-class oral antibiotic that inhibits DNA synthesis in a different way than currently approved antibiotics. Zoliflodacin has been awarded fast track status by the FDA for development as oral treatment for gonorrhea infections, which is likely to translate into significant gains for the gonorrhea therapeutics market in the years to come.

Inquire for a Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=3761

Epistaxis Market is Expected to Represent a Value of Nearly US$ 13 Mn by the End of 2026

Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.

For More Information On This Report, Please Visit: https://www.factmr.com/report/344/epistaxis-market

Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane. Dry nasal membrane leads to increasing occurrences of nosebleeds during the hot, cold and dry weather. Increasing incidences of dry nasal membrane and abnormal nosebleeds is expected to boost demand for epistaxis products during the forecast period.

Manufacturers are focusing on developing epistaxis products that offer improved performance and result. Incorporation of innovation in the epistaxis products has led to more effective and advanced treatment procedures for epistaxis. Innovative treatment procedures include various surgical and non-surgical interventional procedure. Innovative treatment for nasal packing, embolization and warm water irrigation are a few non-interventional surgeries.

Endoscopic litigation of sphenopaletine artery, maxillary, artery litigation and nasal cauterization are the innovative treatments that include surgical intervention. Adoption of innovative surgeries are significantly changing the trends in the global epistaxis market. Moreover, manufacturers are increasingly focusing on developing epistaxis products for the treatment of patients with special medical conditions such as asthma, pregnancy, diabetes and cancer. These factors are expected to contribute towards growth of the global epistaxis market during the forecast period.

To Get Sample Copy of Report please visit: https://www.factmr.com/connectus/sample?flag=S&rep_id=344

With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.

Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.

By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.

Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.

Inquire for the Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=344

About FactMR

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Our laser-like focus on providing fact-based solutions is underpinned by insights gleaned from over 100 million data points, painstakingly gathered over the last decade and consolidated among a diverse range of industry sectors. This has allowed us to patent a proven and tested research methodology where we analyze historical data and compare this with projections for the immediate future to arrive at accurate market forecasts.

Besides in-depth primary and secondary research comprising focused interviews with industry experts and key market stakeholders, our analysts gather real-time data from various social media channels and filter this into our market forecasts to provide the latest updates trending the various global markets.

Contact Us:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: sales@factmr.com

EMS Vehicles Market – Rising Investments in Global Emergency Medical Services to Boost Revenue Growth

Vehicles catering to emergency medical services (EMS) are finding widespread adoption across the global healthcare sector. Innovations and technological advancements are redefining the paradigms of EMS vehicles deployment for critical care functions. A new trend governing the global EMS market is the introduction of bike ambulances – basically two-wheeler EMS vehicles that ply on roads with congested traffic. Especially in countries like India, the increased vehicle population on roads warrants the use of two-wheeled EMS vehicles to address emergency medical issues with speed and efficiency.

For More Information On This Report, Please Visit: https://www.factmr.com/report/837/emergency-medical-services-vehicles-market

Another trend in the global market for EMS vehicles pertains to the launch of driverless automobiles. The global automotive industry has witnessed the introduction of autonomous vehicles and this concept has proliferated the EMS vehicles market as well. The increasing demand for EMS vehicles across various regional healthcare markets – in both developed as well as emerging economies – has created the need to deploy autonomous EMS vehicles in the healthcare industry across the globe. By going driverless, EMS vehicles can free up the paramedical staff to focus on administering critical care without loss of time, thereby increasing the chances of survival of victims and patients. The use of drones to transport medical equipment is also seen as a revolution in the global EMS vehicles market, thereby boosting the growth in adoption and subsequently revenue share of EMS vehicles in the global market.

Across the world, healthcare and medical regulatory bodies are beefing up investments in structured emergency medical services to provide prompt medical aid to patients. With patient convenience and speedy and timely services being the paramount objective behind emergency medical services, healthcare organizations are deploying the necessary services and tools to cater to the needs of patients more efficiently. One of the critical components of emergency medical services are EMS vehicles, which are finding increasing use across hospitals and medical facilities worldwide. Institutions like the World Bank are extending the necessary financial support for emergency medical services across certain regions. This growing leverage on emergency medical services to facilitate critical care is driving revenue growth of the global EMS vehicles market.

While EMS vehicles are being manufactured in large numbers to cater to the rising demands from the global healthcare industry, the pricing structure of EMS vehicles is driven by several key factors. Cost is paramount here – prices of various components and raw materials used in the automotive sector are increasing by the day. Producer price indices for core raw materials such as plastic, aluminum, rolled steel, and resins have skyrocketed in the last 10 years, and this is anticipated to have a cascading effect on the pricing structure of EMS vehicles.

To Get Sample Copy of Report please visit: https://www.factmr.com/connectus/sample?flag=S&rep_id=837

Then again, the deployment of advanced technology in the automotive sector potentially impacts the pricing structure of automobiles and vehicles such as EMS vehicles. State-of-the-art medical equipment installed in EMS vehicles boosts up costs and with healthcare institutions focusing on customization of their EMS vehicles, the price per EMS vehicle is likely to remain Northward in the coming years.

Regulatory compliance is yet another price driver. Manufacturers of EMS vehicles are mandated to cater to the norms and standards prescribed by national traffic authorities as well as the international acts governing motor vehicle safety. These stringent regulations force manufacturers to keep the pricing structure of EMS vehicles at a high market level.

Over the years, the instances of strokes and cardiovascular emergencies have increased in developed economies such as North America and Japan. This presents potential growth opportunities to manufacturers of EMS vehicles in these regions. The deployment of EMS vehicles and subsequent provision of prompt medical aid has successfully reduced the instances of strokes and other emergency medical issues. This has not only augmented the growth trajectory of the EMS vehicles market in North America, but has also boosted manufacturer initiatives in facilitating innovations in the technology underpinning the production of EMS vehicles.

The growing number of road accidents across the world is another factor driving the increased plying of EMS vehicles on roads. Governments across developing regions such as Asia Pacific are enhancing the local emergency medical services scenario and this has led to an increasing demand for EMS vehicles across several countries in the APAC region. Also, a rapidly expanding geriatric population across the globe is leading to rising incidence of cardiovascular diseases and other age-related disorders. EMS vehicles find increasing adoption to address the medical needs of the elderly population – one of the key demographic indicators of growth in revenue of the global market for EMS vehicles.

Inquire for the Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=837

Tissue Expanders Market: Increasing Demand for Reconstructing the Scalp to Drive the Market

Removal of breast attributed to growing cases of breast cancer has led to surge in demand for reconstructing breast. In addition, increasing demand for reconstructing the scalp and forehead skin attributed to skin distinction is expected to contribute towards growth of the global tissue expanders market during the forecast period. Moreover, treatment of cancer diseases leads to severe injuries on neck and face, burns and birth defects. Growing preference for the reconstruction treatments as compared to skin implants or grafts will continue to rev up sales of tissue expanders globally.

For More Information On This Report, Please Visit: https://www.factmr.com/report/340/tissue-expanders-market

Prevalence of breast cancer has led to increasing demand for treatment such as mastectomy and lumpectomy. According to American Society of Plastic Surgeons (ASPS), nearly 17.1 million minimally-invasive and surgical cosmetic procedures were conducted in the U.S. in 2016. Moreover, a recent report by CDC states that breast cancer is the most common type of cancer in women and the most common cause of death as well. Treatment of the breast cancer can lead to breast removal or other injuries on face and neck. Growing need for breast construction will continue to rev up demand for tissue expanders in the global market during the forecast period. Surge in demand for reconstruction of breast and injured forehead, face and neck is expected to contribute towards growth of the tissue expanders market in North America.

Medical or health tourism continues to remain a major trend in various countries of Latin America such as Costa Rica, Brazil and Columbia. Breast reconstruction and plastic surgery are among the leading procedures performed in the Latin America region. Attributed to low prices of the treatment and surgeries performed, demand for plastic surgery is expected to increase in the global market during the forecast period.

However, the tissue expanders market is expected to witness an inhibiting growth in Europe. According to British Association of Aesthetic Plastic Surgeons (BAAPS), ‘Global Fragility’ continues to remain a major driver, due to which the number of cosmetic surgeries performed in U.K. is declining significantly. Declining rate of cosmetic surgeries will continue to dip the sales of tissue expanders globally. Such factors are expected to impact growth of the global tissue expanders market negatively during the forecast period.

To Get Sample Copy of Report please visit: https://www.factmr.com/connectus/sample?flag=S&rep_id=340

Growing need for breast reconstruction has led to surge in demand for anatomical tissue expanders products globally. On the basis of product type, the anatomical tissue expanders segment is expected to represent a significant revenue growth, accounting for a value of over US$ 100 Mn by the end of 2026. Moreover, the anatomical tissue expander product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to generate significant revenues, recording a value of less than US$ 100 Mn by the end of 2017. However, the specialty clinics end user segment is expected to register a robust CAGR through 2026.

By application, the breast reconstruction segment is expected to generate significant revenue growth, accounting for a value of over US$ 150 Mn by the end of 2026. In contrary, the forehead skin and scalp reconstruction application segment is expected to register a healthy CAGR during the forecast period.

Leading market players operating in the global tissue expanders market include PMT Corporation, Sientra Inc., Allergan Plc, Johnson & Johnson, Polytech Health & Aesthetics, Groupe Sebbin, Koken Co. Ltd., AirXpanders Inc., GC Aesthetics and Guangzhou Wanhe Plastic Materials.

Inquire for the Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=340

Automotive Fuse Boxes Market Global Analysis and Forecasts Upto 2028

Automobile sales have remained robust in the recent past, with the International Organization of Motor Vehicle Manufacturers (OICA) estimating nearly 97,000,000 units of automobiles, including commercial vehicles and passenger cars, sold in 2017. This has significantly rubbed off on demand and supply of imperative integral components, such as automotive fuse boxes. Pressing requirement of the automotive industry for upgradation to efficient networks, and greater emphasis on sustainability has been paving avenues for developments in automotive electrical equipment and components. The trend will have a direct impact on development and demand for fuse boxes.

For More Information On This Report, Please Visit: https://www.factmr.com/report/838/automotive-fuse-boxes-market

Advent of electric vehicles, as part of meeting sustainability goals in the automotive sector, has not only brought significant transformation in the industry, but also have impacted the global power market. Majority of future vehicle sales are likely to be those integrated with plug-ins, implying an imminent surge in automotive power demand. Automakers are shifting away from internal combustion engines toward power-driven motors.

Impending plans of Volvo to incorporate electric motors in its new car models, and BMW’s aim at replacing the 7-Series with its electric iNext as the flagship, are key examples of such technology shift. Growing popularity of plug-ins has meant that the power and auto sectors are becoming intertwined. Ripple effects of this trend will significantly rub off on the development and demand for automotive fuse boxes in the near future.

Demand for automotive fuse boxes will be significantly influenced by the rising demand for luxury vehicles among affluent consumers worldwide. Daimler AG recently reported 44% rise in luxury model sales over 2017, and Mercedes reported 21% sales in the U.S. alone in 2017. Luxury car manufacturers in the U.S. and China have witnessed sales exceeding their expectations compared to record lows of the recent past. In India, albeit the car industry has been representing signs of decline, exception is luxury models that have been and will observe a significant growth.

Consumers capable of affording luxury cars are being provided most advanced safety options, laundry list of customization choices, and the latest in technology. These factors, while fuelling luxury car sales worldwide, have significantly rubbed off on development of advanced auto components, thereby influencing demand for automotive fuse boxes on the trail.

The need to avoid uncontrolled and rapid discharge of storage device in case of vehicle accident or equipment malfunction has led automakers to emphasize on fuse-link protection as a key safety feature for equipment and passengers alike. Most of the automobile manufacturers are currently utilizing standard fuse boxes, however development is imperative for reducing size while maintaining safety, reliability and environmental requirements.

To Get Sample Copy of Report please visit: https://www.factmr.com/connectus/sample?flag=S&rep_id=838

Impending implementation of global standards apropos of environment-friendly vehicles, such as the European Commission’s legislative proposal for common safety standard for EVs, are likely to prompt manufacturers to focus on developing EV-compliant products, with integral components such as fuse boxes being one of the primary focus areas. However, challenges remain such as maintaining appropriate safety margin for fuse boxes, predictions pertaining to normal current loading in EVs, and optimization of fuse rating while maintaining cyclic loading and ambient temperature.

Advent of new lightweight materials, increasing feasibility of electric & alternative powertrains, and rapid rise in car-sharing & ridesharing, have changed the way of transportation of people and goods. The new mobility ecosystem resulting from these converging technological and social trends will impact a host of automotive industry players. Global automotive OEMs are eyeing the shift from fixed capital production, product-sale, first-transaction business to being end-to-end mobility service providers, implying profound business model change in the forthcoming years.

Suppliers of automotive components such as fuse boxes, with an aim to access capabilities and assets for competing in the future, are likely to join forces with participants different from the ones in the current, more linear supply chain. The promising future of mobility will have significant impact on demand for auto components, such as fuse boxes, in the foreseeable future.

As demand for electric vehicles continues to rise, vendors of auto components, such as fuse boxes, are focusing on the introduction of the segment-specific products. For example, automotive fuse box manufacturers, such as Eaton, have introduced fuse boxes designed for protecting sensitive equipment.

These fuse boxes include power conversion equipment, high-voltage batteries, and auxiliary circuits in hybrid & electric vehicles. As fuses used in hybrid & electric vehicles require comparatively compact, and weigh significantly lesser than their conventional counterparts, investment-related benefits are making them a viable capitalization area for automotive fuse manufacturers.

Inquire for the Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=838